Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Principal Formulation Development Scientist I - Oxford
Principal Formulation Development Scientist I - Oxford
ImmunocoreHenley on Thames
Principal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreBourton on the WaterPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreStratfield SayePrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreRoushamPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
